Obesity Clinical Trial
Official title:
Blood Glucose Variability in Obese Youth Participating in a Lifestyle Modification Program
Verified date | March 2020 |
Source | Yale University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The purpose of this study is to measure blood glucose variation in youth prior to and after participation in a healthy lifestyle intervention program. The hypothesis is that youth with more severe obesity and those further along in puberty will have more glycemic variability, and that glycemic variability will be improved by participation in the lifestyle intervention program.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | March 2016 |
Est. primary completion date | September 2015 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 7 Years to 16 Years |
Eligibility |
Inclusion Criteria: - Obese (BMI >95 percentile for age based on CDC growth charts) - Willing to wear a CGM initially before and after the Bright Bodies program - Willing to check fingersticks 3 times a day while wearing the CGM - Willing to keep a food record before and after the Bright Bodies program - Be in good general health without other acute or chronic illness that in the judgment of the investigator could interfere with the study or jeopardize subject safety - Able to give consent (permission from parents and subject assent will be required) - Female subjects of reproductive potential must be abstinent or consistently using appropriate family planning methods Exclusion Criteria: - Presence of any medical or psychiatric disorder that may interfere with subject safety or study conduct - Prior participation in the Bright Bodies program. - Diagnosis of diabetes - Participation in a concurrent lifestyle modification (exercise/nutrition) program - Use of any medications known to effect blood glucose levels, including oral or other systemic glucocorticoid therapy - Subjects using herbal supplements will be excluded, due to the unknown effects of these supplements on glucose control - Female subjects who are pregnant, lactating, or unwilling to be tested for pregnancy - Subjects and/or parents who are not proficient in speaking/understanding the English language - Subjects who discontinue participation in the Bright Bodies program during the study period will be excluded from follow-up monitoring |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Yale University | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in blood glucose pre and post meal | Change in blood glucose from meal time to 2-4 hours afterwards, before and after Bright Bodies program | 4 months | |
Secondary | Change in mean number of calories consumed | Change in mean number of calories consumed before and after Bright Bodies program | 4 months | |
Secondary | Change in Glucose exposure | Change in glucose exposure as measured by the area under the curve before and after Bright Bodies program | 4 months | |
Secondary | Change in food consumption breakdown | Change in the percent of kcals from total fat, sugar, and protein of food consumed before and after Bright Bodies program | 4 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |